Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY 14203, USA.
Int J Mol Sci. 2023 Feb 7;24(4):3252. doi: 10.3390/ijms24043252.
Age-related macular degeneration (AMD) is the leading cause of blindness in elderly people, with limited treatment options available for most patients. AMD involves the death of retinal pigment epithelium (RPE) and photoreceptor cells, with mitochondria dysfunction being a critical early event. In the current study, we utilized our unique resource of human donor RPE graded for AMD presence and severity to investigate proteome-wide dysregulation involved in early AMD. Organelle-enriched fractions of RPE were isolated from donors with early AMD ( = 45) and healthy age-matched controls ( = 32) and were analyzed by UHR-IonStar, an integrated proteomics platform enabling reliable and in-depth proteomic quantification in large cohorts. A total of 5941 proteins were quantified with excellent analytical reproducibility, and with further informatics analysis, many biological functions and pathways were found to be significantly dysregulated in donor RPE samples with early AMD. Several of these directly pinpointed changes in mitochondrial functions, e.g., translation, ATP metabolic process, lipid homeostasis, and oxidative stress. These novel findings highlighted the value of our proteomics investigation by allowing a better understanding of the molecular mechanisms underlying early AMD onset and facilitating both treatment development and biomarker discovery.
年龄相关性黄斑变性(AMD)是老年人失明的主要原因,大多数患者的治疗选择有限。AMD 涉及视网膜色素上皮(RPE)和光感受器细胞的死亡,线粒体功能障碍是一个关键的早期事件。在本研究中,我们利用我们独特的、按 AMD 存在和严重程度分级的人类供体 RPE 资源,研究了早期 AMD 中涉及的全蛋白质组失调。从患有早期 AMD 的供体(= 45)和健康年龄匹配的对照者(= 32)中分离出富含细胞器的 RPE 级分,并通过 UHR-IonStar 进行分析,这是一个集成的蛋白质组学平台,能够在大样本量中进行可靠和深入的蛋白质组定量分析。共定量了 5941 种蛋白质,具有出色的分析重现性,并且通过进一步的信息学分析,发现早期 AMD 供体 RPE 样本中的许多生物学功能和途径明显失调。其中一些直接指出了线粒体功能的变化,例如翻译、ATP 代谢过程、脂质稳态和氧化应激。这些新发现突出了我们蛋白质组学研究的价值,使我们能够更好地理解早期 AMD 发病的分子机制,并促进治疗方法的开发和生物标志物的发现。